Bacterial and clinical metabolic signatures and their interactions in obese patients post-bariatric surgery
BMC Gastroenterology · 12.10.2024 · 24 (1)
DOI: 10.1186/s12876-024-03450-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Gastroenterology, online erschienen am 12.10.2024. Verfasst von Mengjie Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, PR China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Gastrectomy, Bariatric Surgery, Feces. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Obesity is a growing health concern in China, closely linked to metabolic disorders such as type 2 diabetes. Laparoscopic Sleeve Gastrectomy (LSG) is effective in promoting weight loss and improving metabolic outcomes. Emerging evidence highlights the role of gut microbiota in metabolic regulation, yet the specific alterations in gut microbiota and their association with metabolic changes post-surgery in Chinese patients remain unclear. Understanding these shifts could provide key insights into optimizing treatment strategies for metabolic improvement following bariatric surgery.
Methods
Stool samples and clinical data were collected from 30 obese patients before and 6 months after surgery. The composition of the gut microbiota was analyzed through 16S rRNA sequencing, and Spearman correlation analysis was used to determine the association between gut microbiota and clinical indicators.
Results
The analysis of 30 patients showed a significant decrease in Body Mass Index (BMI) (36.75 ± 4.09 kg/m 2 vs 26.37 ± 3.47 kg/m 2 , p < 0.0001). Glucose metabolism, including Hemoglobin A1C levels, improved significantly (6.05 ± 0.96 vs 5.05 ± 0.25, p < 0.0001), and liver function as well as serum lipid levels were also notably improved. LSG increased the richness and composition of gut microbiota in obese patients post-surgery. These changes in gut microbiota were closely associated with improved clinical metabolic parameters.
Conclusion
LSG not only significantly reduces body weight while also alleviating metabolic syndrome and comorbidities by altering gut microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, PR China.
- Bariatric and Metabolic Diseases Surgery Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, PR China.
- Neurology Department, Zhongnan Hospital of Wuhan University, Wuhan, 430071, PR China.
- Neurology Department, Zhongnan Hospital of Wuhan University, Wuhan, 430071, PR China. wb001792@whu.edu.cn.
- Department of Hepatobiliary & Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, PR China. lizhen10220@znhospital.cn.
- Bariatric and Metabolic Diseases Surgery Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, PR China. lizhen10220@znhospital.cn.
Zitieren
APA
Hu, M., Xiang, Q., Mei, Z., Gong, C., Pan, D., Liu, Y., & Li, Z. (2024). Bacterial and clinical metabolic signatures and their interactions in obese patients post-bariatric surgery. BMC Gastroenterology, 24(1). https://doi.org/10.1186/s12876-024-03450-1
Vancouver
Hu M, Xiang Q, Mei Z, Gong C, Pan D, Liu Y, et al. Bacterial and clinical metabolic signatures and their interactions in obese patients post-bariatric surgery. BMC Gastroenterology. 2024;24(1). doi:10.1186/s12876-024-03450-1
BibTeX
@article{Hu2024,
author = {Hu, Mengjie and Xiang, Qiaoyuan and Mei, Zixuan and Gong, Cheng and Pan, Dingyu and Liu, Yumin and Li, Zhen},
title = {Bacterial and clinical metabolic signatures and their interactions in obese patients post-bariatric surgery},
journal = {BMC Gastroenterology},
year = {2024},
volume = {24},
number = {1},
doi = {10.1186/s12876-024-03450-1}
}
EUVIMED